Behavioural PharmacologyLoganin (cas 18524-94-2) improves learning and memory impairments induced by scopolamine in mice
-
Add time:09/24/2019 Source:sciencedirect.com
Loganin is an iridoid glycoside found in the Flos lonicerae, Fruit cornus, and Strychonos nux vomica. We investigated the effect of loganin on learning and memory impairments induced by scopolamine (0.5 mg/kg, i.p.), a muscarinic antagonist, using the Y-maze, passive avoidance, and the Morris water maze tests in mice. In the Y-maze test, loganin (40 mg/kg, p.o.) significantly improved the scopolamine-induced memory impairment. In addition, loganin (20 and 40 mg/kg, p.o.) significantly reversed scopolamine-induced impairments measured by the passive avoidance and the Morris water maze tests. A day after the last trial session of the Morris water maze test (probe trial session), loganin (20 and 40 mg/kg) dose-dependently increased the latency time in the target quadrant. Furthermore, loganin significantly inhibited acetylcholinesterase activity in the hippocampus and frontal cortex. Loganin may have anti-amnesic activity that may hold significant therapeutic value in alleviating certain memory impairments observed in Alzheimer's disease.
We also recommend Trading Suppliers and Manufacturers of Loganin (cas 18524-94-2). Pls Click Website Link as below: cas 18524-94-2 suppliers
Prev:Loganin (cas 18524-94-2) enhances long-term potentiation and recovers scopolamine-induced learning and memory impairments
Next:Loganin (cas 18524-94-2) attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Loganin (cas 18524-94-2) protects against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells09/27/2019
- Hepato-protective effects of Loganin (cas 18524-94-2), iridoid glycoside from Corni Fructus, against hyperglycemia-activated signaling pathway in liver of type 2 diabetic db/db mice09/26/2019
- Loganin (cas 18524-94-2) attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products09/25/2019
- Loganin (cas 18524-94-2) enhances long-term potentiation and recovers scopolamine-induced learning and memory impairments09/10/2019
- Loganin (cas 18524-94-2) possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy09/09/2019
- Endocrine pharmacologyLoganin (cas 18524-94-2) protects against pancreatitis by inhibiting NF-κB activation09/08/2019
- Effect of Loganin (cas 18524-94-2) on experimental diabetic nephropathy09/07/2019
- Parentucellia latifolia subsp. latifolia: A potential source for Loganin (cas 18524-94-2) iridoids by HPLC-ESI-MSn technique09/06/2019
- Loganin (cas 18524-94-2) inhibits the inflammatory response in mouse 3T3L1 adipocytes and mouse model☆09/05/2019